AHAnders Helander

Anders Helander

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anders Helander has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bei Patienten auf der Lebertransplantationswarteliste deckt Ätylglucuronide Alkoholkonsum auf, der mit marktüblichen Markern nicht bestimmt werden kann

    by Y. Erim, U. Dahmen, A. Helander, O. Beck, M. Böttcher, J. F. Schlaak, G. Gerken, C. E. Broelsch, W. Senf

    Hintergrund: Seit der ersten Transplantation für einen Patienten mit alkoholtoxischer Leberzirrhose wurde diskutiert, ob Patienten mit einer alkoholtoxischen Leberzirrhose der Transplantation zugeführt werden sollten. Aufgrund eines überraschend guten Outcomes stieg der Anteil der Patienten mit äthyltoxischer Leberzirrhose bis auf ein Drittel aller Lebertransplantationen. Eine sechsmonatige Abstinenzzeit wird jedoch als eine unabdingbare Voraussetzung vor der Lebertransplantation angesehen. Der Nachweis von Rückfällen hat erhebliche Konsequenzen für Patienten, die nicht für eine Transplantation gelistet werden, oder ihren Platz auf der Warteliste vorübergehend verlieren. Übliche biochemische Marker als Parameter des Alkoholkonsums, z.B. Gamma Glutamil Transferase (GGT) und Carbohydrat Defficient Transferrin (CDT) verlieren bei zirrhotischen Veränderungen ihre Aussagefähigkeit. Äthylglukuronid ist ein wasserlöslicher, stabiler, sensitiver und spezifischer Äthanolmetabolit und wird als Rückfallmarker empfohlen. Methode: Im Rahmen einer sechsmonatigen Gruppentherapie zur Stabilisierung der Abstinenz vor der Lebertransplantation, wurde bei jeder Gruppensitzung die Atemalkoholkonzentration gemessen. Auf freiwilliger Basis gaben die Patienten (n=18) Urinproben ab. Weder Therapeuten noch Patienten wurden bezüglich der Äthylglukuronidbestimmungen informiert. Ergebnisse: 119 Mal wurden Atemethanolkonzentrationen und 101 Mal Äthylglukuronid im Urin gemessen. Die Atemethanolmessung ergab ein positives Ergebnis. In den Parallelmessungen konnten Äthylglucuronidkonzentrationen im Urin in 25 Fällen nachgewiesen werden. Insgesamt waren 10(55%) Patienten von Rückfällen betroffen. Alle Patienten verneinten Alkoholkonsum. Schlussfolgerungen: In der Wartezeit auf eine Lebertransplantation haben die Patienten häufiger fortgesetzten kontrollierten Alkoholkonsum als bisher vermutet. Äthylglukuronid weist eine deutlich größere Sensitivität auf als marktübliche Methoden der Ethanolmessung und wird ermöglichen, Konsumverhalten der Patienten genauer zu untersuchen und sie bei ihrem Abstinenzverhalten besser zu unterstützen.

    • 14 February 2001
      • Vol. 98  (7) , 677-83

    [CDT a valuable marker of overconsumption of alcohol. Guidelines for its use in connection with automobile driver examination].

    by B Bjerre, S Borg, A Helander, J O Jeppsson, G Johnson, G Karlsson

    According to the medical regulations for obtaining a driver's license in Sweden, alcohol abuse/dependency constitutes sufficient grounds for denial. In the case of a conviction for gross drunk driving, it is incumbent upon the offender to present a medical certificate verifying a "sober lifestyle". Biological markers are important tools for proving alcohol abuse in each of these contexts. In this connection, CDT analyses play a key role through their high marked specificity for increased alcohol consumption. The authors have agreed upon the guidelines as presented in this paper for determining sobriety as it pertains to possession of a driver's license. Special emphasis is placed on how CDT tests should be used and interpreted in such contexts, as well as their value as evidence in the case of increased CDT levels.

  • Open Access

    Absolute or Relative Measurement of Carbohydrate-deficient Transferrin in Serum? Experiences with Three Immunological Assays

    by Anders Helander

    Individuals who have consumed at least 50–80 g of alcohol per day during the previous week(s) often show an abnormal microheterogeneity of the iron-transporting glycoprotein transferrin in serum (1). After chronic exposure to alcohol, the concentrations of transferrin molecules that lack 2–4 of the four normal terminal sialic acid residues (di-, mono-, and asialo transferrin, respectively) (1) or that lack the entire biantennary carbohydrate chain(s) (2)(3) increase. The presence of increased concentrations of this “carbohydrate-deficient” transferrin (CDT) is a specific and sensitive biochemical indicator of recent excessive drinking (1)(4).


  • Open Access

    Intra- and interindividual variability of carbohydrate-deficient transferrin, γ-glutamyltransferase, and mean corpuscular volume in teetotalers

    by Anders Helander, Erling Vabö, Klas Levin, Stefan Borg

    Blood samples for determination of the biochemical alcohol markers carbohydrate-deficient transferrin (CDT) in serum, γ-glutamyltransferase (GGT) in serum, and erythrocyte mean corpuscular volume (MCV) were collected once every 1–2 weeks over ∼5 months from 10 female and 4 male teetotalers. Mean values for serum CDT (using the CDTectTM assay) ranged from 9.9 to 29.4 units/L (median, 14.2 units/L), and the highest results were obtained in the women. The mean values for serum GGT ranged from 0.15 to 0.49 μkat/L (median, 0.30 μkat/L, or 18 U/L) except for one woman with a very high mean of 3.07 μkat/L. For MCV, the mean values ranged from 79.5 to 91.5 fL. Two women showed several CDT results above the upper reference limit (mean values, 27.6 and 29.4 units/L, respectively); however, their GGT and MCV values fell within the reference intervals. One of these women exhibited an increased total transferrin concentration (mean value, 5.38 g/L), which was possibly related to the use of oral contraceptives and/or a low serum iron concentration. When the CDTect value was expressed relative to total transferrin, a ratio within the reference interval was observed for this woman but not for the other woman with increased CDTect values. The present study demonstrates a considerable variation between individuals in CDT, GGT, and MCV without drinking any alcohol. The results also show that these baseline values are fairly constant over time within the same individual.


    • 1 January 1994
      • Vol. 2, 493-6

    Detection of relapses in alcohol dependent patients using serum carbohydrate deficient transferrin: improvement with individualized reference levels.

    by S Borg, A V Carlsson, A Helander, A M Brandt, O Beck, H Stibler

    Alcohol dependent male outpatients were monitored for a period of six months. Indicators of alcohol consumption were compared using clinical information three times per week, serum levels of carbohydrate deficient transferrin (CDT) weekly and urine samples of 5-hydroxytryptophol daily. Individualized reference values of CDT were calculated by using an increase of three times the lowest coefficient of variation in the group, which meant that an increase of < or = 30% from the lowest value of each individual was considered a significant increase, and therefore an indication of alcohol consumption. By this approach, it was possible to improve the ability to detect relapses in alcohol dependent patients using serum CDT once a week compared to CDT using reference values recommended by the manufacturer.

    • 1 January 1994
      • Vol. 2, 497-502

    The use of 5-hydroxytryptophol as an alcohol intake marker.

    by A Helander, O Beck, S Borg

    5-Hydroxytryptophol (5HTOL) occurs naturally in animals as a metabolite of serotonin. Ethanol interacts with serotonin metabolism to increase the production of 5HTOL at the expense of 5-hydroxyindoleacetic acid (5HIAA). This can be used clinically in the treatment of alcohol dependence to improve the detection of relapse in alcohol drinking, by monitoring daily the urinary 5HTOL/5HIAA ratio. In one experiment the sensitivity of this marker in detecting alcohol drinking the previous day was more than 10-fold greater than measuring urinary ethanol. Genetic polymorphism in alcohol and aldehyde dehydrogenases, which is known to influence the ethanol metabolism, does not confound the clinical use of 5HTOL as a marker. Disulfiram and cyanamide, however, will elevate urinary 5HTOL/5HIAA ratio.